Article
Leucine-Rich Repeat Kinase 2 Influences Fate Decision of Human Monocytes Differentiated from Induced Pluripotent Stem Cells.
PloS one - 1 Jan 2016
Speidel Anna, Felk Sandra, Reinhardt Peter, Sterneckert Jared, Gillardon Frank
Abstract excerpt
Mutations in Leucine-rich repeat kinase 2 (LRRK2) are strongly associated with familial Parkinson's disease (PD). High expression levels in immune cells suggest a role of LRRK2 in regulating the immune system. In this study, we investigated the effect of the LRRK2 (G2019S) mutation in monocytes, using a human stem cell-derived model expressing LRRK2 at endogenous levels. We discovered alterations in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
